marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-14-2023
Bellerophon Therapeutics Income Statement 2011-2024 | BLPH
Annual Income Statement Bellerophon Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
78.6 M | 22.5 M | 54 M | 23.7 M | 40 M | 89.6 M | 9.94 M | 28.3 M | - | - | - | - |
Shares |
9.55 M | 9.5 M | 7.8 M | 4.5 M | 3.83 M | 2.6 M | 1 M | 818 K | - | - | - | - |
Historical Prices |
8.23 | 2.37 | 6.92 | 5.26 | 10.6 | 33.3 | 9.75 | 34.6 | - | - | - | - |
Net Income |
-19.8 M | -17.8 M | -24.7 M | - | - | - | - | - | -59.7 M | -62 M | -46.2 M | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-22.4 M | -20.2 M | -26.3 M | -17.5 M | -27.9 M | -24.6 M | -23.8 M | -46.6 M | -59.8 M | -62 M | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-22.4 M | -20.2 M | -26.3 M | - | - | - | - | - | -59.4 M | -61.6 M | -46.1 M | - |
Operating Expenses |
22.4 M | 20.2 M | 26.3 M | 17.5 M | 27.9 M | 24.6 M | 23.8 M | 48.2 M | - | - | - | - |
General and Administrative Expenses |
6.02 M | 7.15 M | 8.39 M | - | - | - | - | - | - | 9.01 M | - | - |
All numbers in USD currency
Quarterly Income Statement Bellerophon Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
12.2 M | 12.2 M | 10.4 M | 9.65 M | 9.55 M | 9.55 M | 9.55 M | 9.55 M | 9.51 M | 9.51 M | 9.49 M | 9.49 M | 9.49 M | 7.55 M | 4.62 M | 4.57 M | 4.55 M | 4.54 M | 4.35 M | 3.85 M | 3.85 M | 3.82 M | 3.8 M | 55.1 M | 35 M | 33.6 M | 31.9 M | 20.2 M | 13.9 M | 13.1 M | 13.1 M | 13 M | 12.9 M | 12.9 M | 10.2 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-1.92 M | -5.14 M | 2.82 M | - | -5.07 M | -4.1 M | -5.64 M | - | -4.63 M | -3.39 M | -5.46 M | -8 M | -7.93 M | -3.82 M | -4.97 M | -4.08 M | -4.29 M | -4.1 M | -795 K | - | 11.1 M | -11.5 M | 4.1 M | -24.2 M | -7.59 M | -3.93 M | -19.1 M | -7.42 M | -4.2 M | -5.14 M | -7.06 M | -10.8 M | -11.1 M | -11.6 M | -12.9 M | -12.8 M | -15.5 M | -16.9 M | -14.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | 5.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.17 M | -5.26 M | 1.48 M | - | -5.12 M | -6.54 M | -5.64 M | - | -4.8 M | -5.23 M | -5.86 M | -8.15 M | -8.26 M | -5.76 M | -4.11 M | -4.32 M | -4.59 M | -4.22 M | -4.34 M | -4.68 M | -6.83 M | -7.87 M | -8.49 M | -7.31 M | -6.18 M | -6.32 M | -4.78 M | -7.29 M | -4.22 M | -5.16 M | -7.09 M | -10.9 M | -11.2 M | -11.6 M | -12.9 M | -12.8 M | -15.5 M | -17 M | -14.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-2.17 M | -5.26 M | 1.48 M | - | -5.12 M | -6.54 M | -5.64 M | - | -4.8 M | -5.23 M | -5.86 M | -8.15 M | -8.26 M | -5.76 M | -4.11 M | -4.32 M | -4.59 M | -4.22 M | -4.34 M | -4.68 M | -6.83 M | -7.87 M | -8.49 M | -7.31 M | -6.18 M | -6.32 M | -4.78 M | -7.29 M | -4.22 M | -5.16 M | -7.09 M | -10.9 M | -11.2 M | -11.6 M | -12.9 M | -12.8 M | -15.5 M | -17 M | -14.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
2.17 M | 5.26 M | 4.16 M | - | 5.12 M | 6.54 M | 5.64 M | - | 4.8 M | 5.23 M | 5.86 M | 8.15 M | 8.26 M | 5.76 M | 4.11 M | 4.32 M | 4.59 M | 4.22 M | 4.34 M | 4.68 M | 6.83 M | 7.87 M | 8.49 M | 7.31 M | 6.18 M | 6.32 M | 4.78 M | 7.29 M | 4.22 M | 5.16 M | 7.09 M | 10.9 M | 11.4 M | 11.9 M | 14.1 M | 12.8 M | 15.5 M | 17 M | 14.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.63 M | 2.36 M | 1.61 M | - | 1.37 M | 2.05 M | 1.23 M | - | 1.77 M | 1.99 M | 2.28 M | 2.01 M | 2.2 M | 2.31 M | 1.87 M | 1.48 M | 1.33 M | 1.6 M | 2.04 M | 1.87 M | 1.58 M | 2.06 M | 2.11 M | 1.92 M | 1.75 M | 1.63 M | 1.45 M | 2.18 M | 1.74 M | 1.2 M | 1.98 M | 2.53 M | 4.33 M | 3.44 M | 4.57 M | 3.18 M | 3.93 M | 4.19 M | 2.47 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency